Monitoring and management involved using enzyme-linked immunosorbent assay (ELISA) to measure interleukin 15 (IL-15) and vascular endothelial growth factor (VEGF) levels and fluorescence microscopy to observe virus infection efficiency, ensuring accurate tracking of therapeutic efficacy and safety [16]. Here, IL15 is linked to viral infectious disease.